Setting up econometric ARIMA methodology to elucidate European Union nosocomial antimicrobial resistance rate trend evolution based on largest EU database

  14 September 2019

Econometric ARIMA model statistically proved slowdowns and reversions in increase trend of nosocomial E. coli and K. pneumoniae resistance to 3GC and FQ, as well as in resistance of P. aeruginosa resistance to 3GC. P. aeruginosa resistance to FQ shows a descending slope. These brakes and decreased trends proved constitute noteworthy milestones in tackling AMR in Europe.

Author(s): Rafael Ortega-Huedo, Marina Cuesta, Andreas Hoefer, Bruno Gonzalez-Zorn
Effective Surveillance  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

LifeArc

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS





EADA 2023

Emerging Antimicrobials and Diagnostics in AMR 2023

International Matchmaking Symposium EADA 2023
Amsterdam, The Netherlands
16/17 November

More information
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!